Connect with us

Lifestyle

Authorities Seize Fake Medicines Worth Rs 17 Lakh in Ahmedabad

Editorial

Published

on

The Food and Drug Control Administration (FDCA) in Ahmedabad has seized counterfeit allopathic medicines valued at approximately Rs 17 lakh during a series of raids across multiple locations. The operation, which involved inspecting various residences and businesses, resulted in the collection of twenty samples for laboratory testing.

According to H G Koshia, the FDCA commissioner, the counterfeit products included imitations of well-known pharmaceuticals such as Torrent Pharma’s leading medication, Chymoral Forte, as well as Glaxo’s Augmentin, Ipca Company’s Zerodol SP, and Bioswift’s Swifcef. Koshia indicated that preliminary assessments suggest these fake medicines were produced using chalk powder and purchased from other states in cash at half the legitimate price, often without proper invoices.

The FDCA’s investigation stemmed from tips received regarding this illicit operation. Raids were executed in neighborhoods including Vatva, Amraiwadi, and Bapunagar. In addition to the Ahmedabad raids, authorities expanded their efforts, targeting shops in Vadodara, the Katargam area of Surat, and Rajkot, successfully seizing additional stock of counterfeit medicines.

The implications of this operation extend beyond immediate financial loss. The presence of fake medicines poses significant health risks to consumers, potentially leading to ineffective treatment and adverse health outcomes. The FDCA’s proactive measures highlight the ongoing efforts to combat the sale of counterfeit drugs, which undermine public health and safety.

With the samples now sent for testing, further information regarding the exact nature of these counterfeit products and their potential impact on consumers is awaited. Authorities remain vigilant in their pursuit to dismantle such illegal operations and protect the integrity of the pharmaceutical market.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.